115 related articles for article (PubMed ID: 11273228)
1. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use.
Palepu A; Yip B; Miller C; Strathdee SA; O'Shaughnessy MV; Montaner JS; Hogg RS
AIDS; 2001 Feb; 15(3):423-4. PubMed ID: 11273228
[No Abstract] [Full Text] [Related]
2. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
Lesko CR; Tong W; Moore RD; Lau B
AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
[TBL] [Abstract][Full Text] [Related]
3. 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
Duran S; Solas C; Spire B; Carrieri MP; Fuzibet JG; Costagliola D; Lacarelle B; Moatti JP;
AIDS; 2001 May; 15(8):1075-7. PubMed ID: 11399998
[No Abstract] [Full Text] [Related]
4. Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.
Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
Antivir Ther; 2004 Apr; 9(2):229-35. PubMed ID: 15134185
[TBL] [Abstract][Full Text] [Related]
5. Impact of injecting drug use on the interruption of antiretroviral therapies.
Muga R; Egea JM; Sanvisens A; Arnal J; Tural C; Tor J; Rey-Joly C
J Epidemiol Community Health; 2004 Apr; 58(4):286-7. PubMed ID: 15026439
[No Abstract] [Full Text] [Related]
6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
7. Issues in antiretroviral therapy: when to start?
Boyle BA
AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
[No Abstract] [Full Text] [Related]
8. The effect of history of injection drug use and alcoholism on HIV disease progression.
Lima VD; Kerr T; Wood E; Kozai T; Salters KA; Hogg RS; Montaner JS
AIDS Care; 2014 Jan; 26(1):123-9. PubMed ID: 23767757
[TBL] [Abstract][Full Text] [Related]
9. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
10. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
[TBL] [Abstract][Full Text] [Related]
11. Staging for antiretroviral therapy among HIV-infected drug users.
Wood E; Hogg RS; Bonner S; Kerr T; Li K; Palepu A; Guillemi S; Schechter MT; Montaner JS
JAMA; 2004 Sep; 292(10):1175-7. PubMed ID: 15353528
[No Abstract] [Full Text] [Related]
12. Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs.
Pradier C; Carrieri P; Bentz L; Spire B; Dellamonica P; Moreau J; Moatti JP
Int J STD AIDS; 2001 May; 12(5):324-8. PubMed ID: 11368807
[TBL] [Abstract][Full Text] [Related]
13. When to start antiretroviral therapy.
Wang C; Masho SW; Nixon DE
Curr HIV/AIDS Rep; 2006 Jul; 3(2):66-73. PubMed ID: 16608662
[TBL] [Abstract][Full Text] [Related]
14. Is antiretroviral therapy modifying the HIV epidemic?
Grulich AE; Wilson DP
Lancet; 2010 Nov; 376(9755):1824; author reply 1825. PubMed ID: 21111902
[No Abstract] [Full Text] [Related]
15. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
Tun W; Gange SJ; Vlahov D; Strathdee SA; Celentano DD
Clin Infect Dis; 2004 Apr; 38(8):1167-74. PubMed ID: 15095224
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
18. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.
Rasmussen LD; Dybdal M; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Jensen J; Pedersen L; Sørensen HT; Obel N
HIV Med; 2011 Apr; 12(4):202-10. PubMed ID: 20726905
[TBL] [Abstract][Full Text] [Related]
19. Validity of self-reported adherence among injection drug users.
Kerr T; Hogg RS; Yip B; Tyndall MW; Montaner J; Wood E
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors in HIV-infected injecting drug users in Amsterdam: cumulative incidence, determinants and impact.
Schinkel J; Coutinho RA; van Ameijden EJ
AIDS; 1998 Jul; 12(10):1247-9. PubMed ID: 9677178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
